SCHEMBL5375933

SCHEMBL5375933

CSc1nsc(OCc2ncccn2)n1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 3/20 0.33
TSHR P16473 3/20 0.33
MAPK1 P28482 3/20 0.33
LMNA P02545 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KMT2A Q03164 5/20 0.33
MEN1 O00255 3/20 0.33
ABCG2 Q9UNQ0 1/20 0.32
MAPT P10636 1/20 0.31
HSD17B10 Q99714 1/20 0.30
NPC1 O15118 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5377736 0.79 LMNA (0.47) RAB9ASMN1; SMN2ALDH1A1TSHRMAPK1
SCHEMBL5398160 0.78 MEN1 (0.39) RAB9ASMN1; SMN2ALDH1A1TSHRMAPK1
SCHEMBL4799608 0.76 SMN1; SMN2 (0.42) RAB9ASMN1; SMN2ALDH1A1TSHRMAPK1
SCHEMBL5378284 0.76 TDP1 (0.39) RAB9ASMN1; SMN2ALDH1A1TSHRMAPK1
SCHEMBL5387247 0.75 MAPK1 (0.35) RAB9ASMN1; SMN2ALDH1A1TSHRMAPK1
SCHEMBL5417437 0.75 MEN1 (0.41) RAB9ASMN1; SMN2ALDH1A1TSHRMAPK1
SCHEMBL5383959 0.75 RAB9A (0.33) RAB9ASMN1; SMN2ALDH1A1TSHRMAPK1
SCHEMBL5373443 0.75 MAPT (0.41) ALDH1A1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL4799136 0.75 LMNA (0.41) RAB9ASMN1; SMN2ALDH1A1TSHRMAPK1
SCHEMBL5378771 0.74 TDP1 (0.56) RAB9ASMN1; SMN2ALDH1A1MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-20050215578-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-09-29 US disclosed
EP-1475374-A1 THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215578-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH RAB9A 1998/4885SMN1; SMN2 3880/4885ALDH1A1 654/4885
US-20070293510-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH RAB9A 2211/4885SMN1; SMN2 3891/4885ALDH1A1 683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.